Microbix Biosystems Inc. (MBX.TO)
| Previous Close | 0.3400 |
| Open | 0.3350 |
| Bid | 0.3350 x 0 |
| Ask | 0.3400 x 0 |
| Day's Range | 0.3350 - 0.3400 |
| 52 Week Range | 0.2300 - 0.4700 |
| Volume | |
| Avg. Volume | 72,759 |
| Market Cap | 46.722M |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | 11.33 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sept 02, 1999 |
| 1y Target Est | N/A |
- GlobeNewswire
Microbix Presenting at the 2024 Bloom Burton Conference
MISSISSAUGA, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Center, North Building, on April 16 and 17, 2024. The Conference provides an opportunity to connect with Canadian, U.S., and international investors who are in
- GlobeNewswire
Microbix Announces Annual and Special Meeting Voting Results
MISSISSAUGA, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held on March 27, 2024. At the Meeting, 42.64% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the Meeting. Details of all resolut
- GlobeNewswire
Microbix’s Clot-Buster Drug Project Advances
Sequel Pharma Executes Agreement with CDMO for Drug Substance ProductionMISSISSAUGA, Canada, March 14, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has executed, with support from Microbix, an agreement with a leading international contract development and manufacturing organization (“CDMO”) for production of the
